-
1
-
-
0028129023
-
The Royal Marsden Hospital pilot tamoxifen chemoprevention trial
-
Powles T.J., Jones A.L., Ashley S.E., O'Brien M.E.R., Tidy V.A., Treleavan J., Cosgrove D., Nash A.G., Sacks N., Baum M., McKinna J.A., Davey J.B. The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Breast Cancer Res. Treat. 31:1994;73-82.
-
(1994)
Breast Cancer Res. Treat.
, vol.31
, pp. 73-82
-
-
Powles, T.J.1
Jones, A.L.2
Ashley, S.E.3
O'Brien, M.E.R.4
Tidy, V.A.5
Treleavan, J.6
Cosgrove, D.7
Nash, A.G.8
Sacks, N.9
Baum, M.10
McKinna, J.A.11
Davey, J.B.12
-
2
-
-
0028208456
-
Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14
-
NSABP Contributors, Fisher B., Costantino J.P., Redmond C.K., Fisher E.R., Wickerham D.L., Cronin W.M. Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J. Natl. Cancer Inst. 86:1994;527-537.
-
(1994)
J. Natl. Cancer Inst.
, vol.86
, pp. 527-537
-
-
Nsabp Contributors1
Fisher, B.2
Costantino, J.P.3
Redmond, C.K.4
Fisher, E.R.5
Wickerham, D.L.6
Cronin, W.M.7
-
3
-
-
0027428568
-
Major differences in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Cr1:CD(BR) rats
-
Hard G.C., Iatropoulos M.J., Jordan K., Radi L., Kaltenberg O.P., Imondi A.R., Williams G.M. Major differences in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Cr1:CD(BR) rats. Cancer Res. 53:1993;4534-4541.
-
(1993)
Cancer Res.
, vol.53
, pp. 4534-4541
-
-
Hard, G.C.1
Iatropoulos, M.J.2
Jordan, K.3
Radi, L.4
Kaltenberg, O.P.5
Imondi, A.R.6
Williams, G.M.7
-
4
-
-
0027201501
-
Two-year carcinogenicity study of tamoxifen in Alderly Park Wistar-derived rats
-
Greaves P., Goonetilleke R., Nunn G., Topham J., Orton T. Two-year carcinogenicity study of tamoxifen in Alderly Park Wistar-derived rats. Cancer Res. 53:1993;3919-3924.
-
(1993)
Cancer Res.
, vol.53
, pp. 3919-3924
-
-
Greaves, P.1
Goonetilleke, R.2
Nunn, G.3
Topham, J.4
Orton, T.5
-
5
-
-
0000151348
-
-
in: D.R. Laurence, A.E.M. McLean, M. Weatherall (Eds.), Academic Press, New York
-
M.J. Tucker, H.K. Adams, J.S. Patterson, Tamoxifen, in: D.R. Laurence, A.E.M. McLean, M. Weatherall (Eds.), Safety Testing of New Drugs, Academic Press, New York, 1984, pp. 125-161.
-
(1984)
Safety Testing of New Drugs
, pp. 125-161
-
-
Tucker, M.J.1
Adams, H.K.2
Patterson, J.S.3
Tamoxifen4
-
6
-
-
0027054733
-
Genotoxic potential of tamoxifen and analogues in female Fischer F344/N rats, DBA/2 and C57Bl/6 mice and in human MCL-5 cells
-
White I.N.H., De Matteis F., Davies A., Smith L.L., Crofton Sleigh C., Venitt S., Hewer A., Phillips D.H., Crofton Sleigh C. Genotoxic potential of tamoxifen and analogues in female Fischer F344/N rats, DBA/2 and C57Bl/6 mice and in human MCL-5 cells. Carcinogenesis. 13:1992;2197-2203.
-
(1992)
Carcinogenesis
, vol.13
, pp. 2197-2203
-
-
White, I.N.H.1
De Matteis, F.2
Davies, A.3
Smith, L.L.4
Crofton Sleigh, C.5
Venitt, S.6
Hewer, A.7
Phillips, D.H.8
Crofton Sleigh, C.9
-
7
-
-
0026319776
-
Cytochrome P450 mediated action and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: Possible involvement of the flavin-containing monooxygenases in tamoxifen activation
-
Mani C., Kupfer D. Cytochrome P450 mediated action and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of the flavin-containing monooxygenases in tamoxifen activation. Cancer Res. 51:1991;6052-6058.
-
(1991)
Cancer Res.
, vol.51
, pp. 6052-6058
-
-
Mani, C.1
Kupfer, D.2
-
9
-
-
0030069966
-
Tamoxifen metabolic activation: Comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo
-
Moorthy B., Sriram P., Pathak D.N., Bodell W.J., Randerath K. Tamoxifen metabolic activation: Comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo. Cancer Res. 56:1996;53-57.
-
(1996)
Cancer Res.
, vol.56
, pp. 53-57
-
-
Moorthy, B.1
Sriram, P.2
Pathak, D.N.3
Bodell, W.J.4
Randerath, K.5
-
10
-
-
0028860187
-
Dose-response studies of MeIQx in rat liver and liver DNA at low doses
-
Frantz C.E., Bangerter C., Fultz W., Mayer K.M., Vogel J.S., Turteltaub K.W. Dose-response studies of MeIQx in rat liver and liver DNA at low doses. Carcinogenesis. 16:1995;367-373.
-
(1995)
Carcinogenesis
, vol.16
, pp. 367-373
-
-
Frantz, C.E.1
Bangerter, C.2
Fultz, W.3
Mayer, K.M.4
Vogel, J.S.5
Turteltaub, K.W.6
-
11
-
-
0028361529
-
Accelerator mass spectrometry for measuring low-dose carcinogen binding to DNA
-
Felton J.S., Turteltaub K.W. Accelerator mass spectrometry for measuring low-dose carcinogen binding to DNA. Environ. Health Perspect. 102:1994;450-452.
-
(1994)
Environ. Health Perspect.
, vol.102
, pp. 450-452
-
-
Felton, J.S.1
Turteltaub, K.W.2
-
13
-
-
0029052183
-
32P-postlabelling in three rat stains exposed to dietary tamoxifen: The relationship between cell proliferation and liver tumour formation
-
32P-postlabelling in three rat stains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formation. Carcinogenesis. 16:1995;1299-1304.
-
(1995)
Carcinogenesis
, vol.16
, pp. 1299-1304
-
-
Carthew, P.1
Rich, K.J.2
Martin, E.A.3
De Matteis, F.4
Lim, C.K.5
Manson, M.M.6
Festing, M.7
White, I.N.H.8
Smith, L.L.9
-
14
-
-
0028210878
-
DNA adduct formation by tamoxifen with rat and human liver microsomal activation systems
-
Pathak D.N., Bodell W.J. DNA adduct formation by tamoxifen with rat and human liver microsomal activation systems. Carcinogenesis. 15:1994;529-532.
-
(1994)
Carcinogenesis
, vol.15
, pp. 529-532
-
-
Pathak, D.N.1
Bodell, W.J.2
-
15
-
-
0027347175
-
Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: A new technique for tracing isotope-labelled DNA adduction
-
IARC, Lyon
-
K.W. Turteltaub, J.S. Vogel, C.E. Frantz, F. Fultz, Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: a new technique for tracing isotope-labelled DNA adduction, in: D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.), Postlabeling Methods for Detection of DNA Adducts, IARC, Lyon, 1993, pp. 293-301.
-
(1993)
Postlabeling Methods for Detection of DNA Adducts
, pp. 293-301
-
-
Turteltaub, K.W.1
Vogel, J.S.2
Frantz, C.E.3
Fultz, F.4
-
16
-
-
0030050137
-
Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen
-
Osborne M.R., Hewer A., Hardcastle I.R., Carmichael P.L., Phillips D.H. Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen. Cancer Res. 56:1996;66-71.
-
(1996)
Cancer Res.
, vol.56
, pp. 66-71
-
-
Osborne, M.R.1
Hewer, A.2
Hardcastle, I.R.3
Carmichael, P.L.4
Phillips, D.H.5
-
17
-
-
0022491941
-
Modified Edman degredation applied to hemoglobin adducts by a modified Edman degredation method
-
Tornqvist M., Mowrer J., Jensen S., Ehrenberg L. Modified Edman degredation applied to hemoglobin adducts by a modified Edman degredation method. Anal. Biochem. 154:1986;255-266.
-
(1986)
Anal. Biochem.
, vol.154
, pp. 255-266
-
-
Tornqvist, M.1
Mowrer, J.2
Jensen, S.3
Ehrenberg, L.4
-
18
-
-
0026771023
-
The detection of DNA adducts, DNA base changes and chromosome damage for the assessment of exposure to genotoxic pollutants
-
Jones N.J., Parry J.M. The detection of DNA adducts, DNA base changes and chromosome damage for the assessment of exposure to genotoxic pollutants. Aquat. Toxicol. 22:1992;323-343.
-
(1992)
Aquat. Toxicol.
, vol.22
, pp. 323-343
-
-
Jones, N.J.1
Parry, J.M.2
-
19
-
-
0028670421
-
Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes
-
Mani C., Pearce R., Parkinson A., Kupfer D. Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes. Carcinogenesis. 15:1994;2715-2720.
-
(1994)
Carcinogenesis
, vol.15
, pp. 2715-2720
-
-
Mani, C.1
Pearce, R.2
Parkinson, A.3
Kupfer, D.4
-
20
-
-
0029985407
-
Activation of tamoxifen and its metabolite α-hydroxytamoxifen to DNA-binding products: Comparisons between human, rat and mouse hepatocytes
-
Phillips D.H., Carmichael P.L., Hewer A., Cole K.J., Hardcastle I.R., Poon G.K., Keough A., Strain A.J., Keogh A. Activation of tamoxifen and its metabolite α-hydroxytamoxifen to DNA-binding products: Comparisons between human, rat and mouse hepatocytes. Carcinogenesis. 17:1996;89-94.
-
(1996)
Carcinogenesis
, vol.17
, pp. 89-94
-
-
Phillips, D.H.1
Carmichael, P.L.2
Hewer, A.3
Cole, K.J.4
Hardcastle, I.R.5
Poon, G.K.6
Keough, A.7
Strain, A.J.8
Keogh, A.9
-
21
-
-
0028177045
-
A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes
-
Lim C.K., Yuan Z., Lamb J.H., White I.N.H., De Matteis F., Smith L.L. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes. Carcinogenesis. 15:1994;589-593.
-
(1994)
Carcinogenesis
, vol.15
, pp. 589-593
-
-
Lim, C.K.1
Yuan, Z.2
Lamb, J.H.3
White, I.N.H.4
De Matteis, F.5
Smith, L.L.6
-
22
-
-
0029866506
-
Evidence that the catechol 3,4-dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins
-
Dehal S.S., Kupfer D. Evidence that the catechol 3,4-dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins. Cancer Res. 56:1996;1283-1290.
-
(1996)
Cancer Res.
, vol.56
, pp. 1283-1290
-
-
Dehal, S.S.1
Kupfer, D.2
-
23
-
-
0028172242
-
α-Hydroxytamoxifen, a metabolite of tamoxifen with exceptionally high DNA binding activity in rat hepatocytes
-
Phillips D.H., Carmichael P.L., Hewer A., Cole K.J., Poon G.K. α-Hydroxytamoxifen, a metabolite of tamoxifen with exceptionally high DNA binding activity in rat hepatocytes. Cancer Res. 54:1995;5518-5522.
-
(1995)
Cancer Res.
, vol.54
, pp. 5518-5522
-
-
Phillips, D.H.1
Carmichael, P.L.2
Hewer, A.3
Cole, K.J.4
Poon, G.K.5
-
24
-
-
0028979277
-
DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro
-
Hemminki K., Widlak P., Hou S.M. DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro. Carcinogenesis. 16:1995;1661-1664.
-
(1995)
Carcinogenesis
, vol.16
, pp. 1661-1664
-
-
Hemminki, K.1
Widlak, P.2
Hou, S.M.3
-
26
-
-
0029978834
-
Lack of genotoxicity of tamoxifen in human endometrium
-
Carmichael P.L., Ugwumadu A.H.N., Neven P., Hewer A.J., Poon G.K., Phillips D.H. Lack of genotoxicity of tamoxifen in human endometrium. Cancer Res. 56:1996;1475-1479.
-
(1996)
Cancer Res.
, vol.56
, pp. 1475-1479
-
-
Carmichael, P.L.1
Ugwumadu, A.H.N.2
Neven, P.3
Hewer, A.J.4
Poon, G.K.5
Phillips, D.H.6
-
27
-
-
0029815539
-
Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: Comparison with DNA adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen
-
Pathak D.N., Pongracz K., Bodell W.J. Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: Comparison with DNA adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen. Carcinogenesis. 17:1996;1785-1790.
-
(1996)
Carcinogenesis
, vol.17
, pp. 1785-1790
-
-
Pathak, D.N.1
Pongracz, K.2
Bodell, W.J.3
-
28
-
-
0029745072
-
Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients
-
Hemminki K., Rajaniemi H., Lindahl B., Moberger B. Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients. Cancer Res. 56:1996;4374-4377.
-
(1996)
Cancer Res.
, vol.56
, pp. 4374-4377
-
-
Hemminki, K.1
Rajaniemi, H.2
Lindahl, B.3
Moberger, B.4
|